| Primary information |
|---|
| ID | 20589 |
| Pubchem ID | NA |
| Name | 10;11-dihydro-12-oxo-LTB4 |
| Description | 10;11-dihydro-12-oxo-LTB4 is formed when leukotriene B4 (LTB4) is metabolized by beta-oxidation.LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). |
| Synonym | 12-oxo-(5S)-Hydroxy-(6Z;8E;14Z)-eicosatrienoate; 12-oxo-(5S)-Hydroxy-(6Z;8E;14Z)-eicosatrienoic acid; 12-oxo-(5S)-Hydroxy-(6Z;8E;14Z)-eicosatrienoic acid anion; 12-oxo-10;11-dihydro-LTB(;4) |
| Molecular Weight | 336.4657 |
| Formula | C20H32O4 |
| IUPAC | (5R;6Z;8E;14Z)-5-hydroxy-12-oxoicosa-6;8;14-trienoic acid |
| SMILE | CCCCCC=C/CC(=O)CCC=CC=C/[C@H](O)CCCC(O)=O |
| PDB ID | NA |
| KEGG | NA |
| HMDB ID | HMDB0012498 |
| Melting Point (Degree C) | NA |
| Water Solubility | NA |
| Drugbank ID | NA |
| Receptor | NA |
| Reference | HMDB
|